patentsmania.com
US patents database



Search:    

Health And Medicine / Drug, Bio-affecting And Body Treating Compositions / Peptide Containing (e.g., Protein, Peptones, Fibrinogen, Etc.) Doai


Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents

Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents

Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents

Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents

Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity

Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity

Shaped, flavored articles and method of producing same

Shaped, flavored articles and method of producing same

Biodegradable microspheres as a carrier for macromolecules

Biodegradable microspheres as a carrier for macromolecules

Local delivery of fibrinolysis enhancing agents

Local delivery of fibrinolysis enhancing agents

Gels for encapsulation of biological materials

Gels for encapsulation of biological materials

Hemostatic patch

Hemostatic patch

Hemostatic patch

Hemostatic patch

Particles, method of preparing said particles and uses thereof

Particles, method of preparing said particles and uses thereof

Topical use of IGF-II for wound healing

Topical use of IGF-II for wound healing

Prophylactic and theraputic treatment of group A streptococcal infection

Prophylactic and theraputic treatment of group A streptococcal infection

Therapeutic treatment of group A streptococcal infections

Therapeutic treatment of group A streptococcal infections

Therapeutic treatment of group A streptococcal infections

Therapeutic treatment of group A streptococcal infections

Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses

Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses

Topical treatment of streptococcal infections

Topical treatment of streptococcal infections

Bacterial plasmin binding protein and methods of use thereof

Bacterial plasmin binding protein and methods of use thereof

Use of bacterial phage associated lysing enzymes for treating various illnesses

Use of bacterial phage associated lysing enzymes for treating various illnesses

Bacterial phage associated lysing enzymes for treating dermatological infections

Bacterial phage associated lysing enzymes for treating dermatological infections

Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract

Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract

Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections

Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections

Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections

Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections

Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract

Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract

Use of bacterial phage associated lysing enzymes for treating bacterial infections of the mouth and teeth

Use of bacterial phage associated lysing enzymes for treating bacterial infections of the mouth and teeth

Composition for treatment of an ocular bacterial infection

Composition for treatment of an ocular bacterial infection

Method of treating upper resiratory illnesses

Method of treating upper resiratory illnesses

Methods of treatment using Alzheimer's amyloid polypeptide derivatives

Methods of treatment using Alzheimer's amyloid polypeptide derivatives

Treatment of autoimmune diseases by aerosol administration of autoantigens

Treatment of autoimmune diseases by aerosol administration of autoantigens

Treatment of autoimmune diseases through administration by inhalation of autoantigens

Treatment of autoimmune diseases through administration by inhalation of autoantigens

Treatment of autoimmune diseases by aerosol administration of autoantigens

Treatment of autoimmune diseases by aerosol administration of autoantigens

Prevention of autoimmune diseases by aerosol administration of autoantigens

Prevention of autoimmune diseases by aerosol administration of autoantigens

Treatment of autoimmune diseases by aerosol administration of autoantigens

Treatment of autoimmune diseases by aerosol administration of autoantigens

Treatment of autoimmune arthritis by oral administration of type I or type III collagen

Treatment of autoimmune arthritis by oral administration of type I or type III collagen

Alteration of immune response using pan DR-binding peptides

Alteration of immune response using pan DR-binding peptides

Methods and compositions for the detection of soluble β-amyloid peptide

Methods and compositions for the detection of soluble β-amyloid peptide

Treatment of multiple sclerosis by oral administration of bovine myelin

Treatment of multiple sclerosis by oral administration of bovine myelin

Materials and methods for treatment of plaquing diseases

Materials and methods for treatment of plaquing diseases

Aβ peptides that modulate β-amyloid aggregation

Aβ peptides that modulate β-amyloid aggregation

Treatment of multiple sclerosis by oral administration of autoantigens

Treatment of multiple sclerosis by oral administration of autoantigens

Treatment of immune diseases by oral administration of autoantigens

Treatment of immune diseases by oral administration of autoantigens

Methods of detection of amyloidogenic proteins

Methods of detection of amyloidogenic proteins

Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent

Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent

Adjuvant formulation comprising a submicron oil droplet emulsion

Adjuvant formulation comprising a submicron oil droplet emulsion

Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Cationic amphiphile compositions for intracellular delivery of therapeutic molecules

Cationic amphiphile compositions for intracellular delivery of therapeutic molecules

Process for producing sustained-release preparation by in-water drying

Process for producing sustained-release preparation by in-water drying

Delivery of drugs to the lower GI tract

Delivery of drugs to the lower GI tract

Means for removing microorganisms from tissue

Means for removing microorganisms from tissue

Sustained and controlled release of water insoluble polypeptides

Sustained and controlled release of water insoluble polypeptides


#3,534 Previous [1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next




Advertisements  Advertisements